How Well Do You Know Your Thyroid? Take Our Quiz!

Robert Califf, M.D., urges patients and those at risk of illness to find trustworthy health care providers who can help them navigate a fragmented medical system.

A panelist discusses how the dexamethasone suppression test (DST) serves as a simple, cost-effective screening tool for cortisol excess, with proper timing and interpretation of both cortisol and dexamethasone levels being essential for accurate diagnosis and guiding further evaluation.

A review of 33 studies shows that people who follow healthy diets have up to a 23% lower risk of developing Type 2 diabetes — regardless of ethnicity.

BMI may not be enough — body fat percentage is a better predictor of long-term health risks.

People with Type 2 diabetes are significantly more likely to face financial hardships, including debt, poor credit and even bankruptcy.

Daily walking — even well below 10,000 steps — can dramatically improve long-term health, new research shows.

Finerenone gains FDA approval, offering new hope for patients with heart failure with preserved ejection fraction.

Summer fun can complicate blood sugar control — Jennifer Sherr, M.D., Ph.D., explains how to stay one step ahead of diabetic risks.

Planning a pregnancy with diabetes? Pre-conception care can dramatically lower risks and help ensure a healthy start for both you and your baby.

Actor Anthony Anderson shares how losing his father to diabetes and facing his own diagnosis turned him into a passionate patient advocate.

A once-daily oral pill for Type 2 diabetes shows significant hemoglobin A1c and weight loss benefits, offering a convenient alternative to injections.

A groundbreaking stem cell therapy offers hope for patients with Type 1 diabetes, enabling insulin independence for many.

A panelist discusses how cortisol excess often goes undetected in patients with poorly controlled type 2 diabetes and resistant hypertension, emphasizing the importance of proactive screening to improve diagnosis and treatment outcomes and reduce long-term complications.

A panelist discusses how abnormal dexamethasone suppression test (DST) results may indicate cortisol overproduction, emphasizing the importance of ruling out false-positive and false-negative results before proceeding to adrenal imaging for accurate diagnosis and targeted treatment.

Robert Califf, M.D., urges patients and those at risk of illness to find trustworthy health care providers who can help them navigate a fragmented medical system.

A panelist discusses how the dexamethasone suppression test (DST) serves as a simple, cost-effective screening tool for cortisol excess, with proper timing and interpretation of both cortisol and dexamethasone levels being essential for accurate diagnosis and guiding further evaluation.